AXIM Biotechnologies, Inc. announced that it has entered into a securities purchase agreement with Catalina Valencia for a private placement of 3,861,004 restricted shares at a price of $0.0259 per share for gross proceeds of $100,000.0036 on August 24, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0095 USD | +9.20% | -5.94% | -50.00% |
04-16 | AXIM Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-15 | AXIM Biotechnologies, Inc. announced that it has received $0.814555 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 2.42M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- AXIM Stock
- News AXIM Biotechnologies, Inc.
- AXIM Biotechnologies, Inc. announced that it expects to receive $0.1 million in funding